REPROCELL invests in Histocell, S.L. a Spain-based CDMO
Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings.
Personalized medicine in Breast Cancer: Personalization Starts with Screening
Personalized medicine in Breast Cancer: Personalization Starts with Screening Incidences of Breast cancer (BC) are on rapid rise (by 39% over past two decades) making it the most common malignancy among Indian women. Epidemiology of breast cancer differs significantly in Indian women from Western population. Current trends point out that a higher proportion of the…